 |
|
Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia
Kyung Nam Koh (Koh KN), Meerim Park (Park M), Bo Eun Kim (Kim BE), Ho Joon Im (Im HJ), Chan-Jeoung Park (Park CJ), Seongsoo Jang (Jang S), Hyun Sook Chi (Chi HS), Jong Jin Seo (Seo JJ)
Clin Exp Pediatr. 2010;53(11):957-964. Published online 2010 Nov 30 DOI: https://doi.org/10.3345/kjp.2010.53.11.957
|
|
Citations to this article as recorded by
 Toward the Cure of Acute Lymphoblastic Leukemia in Children in China
Si-Liang Chen, Hui Zhang, Robert Peter Gale, Jing-Yan Tang, Ching-Hon Pui, Sai-Juan Chen, Yang Liang
JCO Global Oncology.2021; (7): 1176. CrossRef A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients
Prashant R. Tembhare, Papagudi G. Subramanian PG, Sitaram Ghogale, Gaurav Chatterjee, Nikhil V. Patkar, Avinash Gupta, Rahul Shukla, Yajamanam Badrinath, Nilesh Deshpande, Gaurav Narula, Pearl Rodrigues, Karishma Girase, Dilshad Dhaliwal, Maya Prasad, Dha
Cytometry Part B: Clinical Cytometry.2020; 98(1): 57. CrossRef Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detection
Ramalingam Thulasi Raman, Muthu Anurekha, Vaidhyanathan Lakshman, Ramakrishnan Balasubramaniam, Uppuluri Ramya, Raj Revathi
Leukemia & Lymphoma.2020; 61(8): 1974. CrossRef Bone marrow recovery of hematopoietic stem cells and microenvironment after chemotherapy in childhood acute lymphoblastic leukemia: consecutive observations according to chemotherapy schedule
Sang Hyuk Park, Mee Jeong Lee, Chan-Jeoung Park, Seongsoo Jang, Eul-Ju Seo, Ho-Joon Im, Jong-Jin Seo
Pediatric Hematology and Oncology.2019; 36(4): 222. CrossRef Implementation of a simplified flow cytometric assays for minimal residual disease monitoring in childhood acute lymphoblastic leukemia
Ester Vinhas, Norma Lucena‐Silva, Francisco Pedrosa
Cytometry Part B: Clinical Cytometry.2018; 94(1): 94. CrossRef Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study
Kyung-Nam Koh, Ho Joon Im, Hyery Kim, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo, Young Tak Lim, Jun Eun Park, Byung-Kiu Park, Hyeon Jin Park, Jong Jin Seo
Journal of Korean Medical Science.2017; 32(4): 642. CrossRef Influence of Musculoskeletal Manifestations as the Only Presenting Symptom in B-Cell Acute Lymphoblastic Leukemia
Seungcheol Kang, Ho Joon Im, Kunhyung Bae, Soo-Sung Park
The Journal of Pediatrics.2017; 182: 290. CrossRef Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013
Allen E J Yeoh, Daryl Tan, Chi-Kong Li, Hiroki Hori, Eric Tse, Ching-Hon Pui
The Lancet Oncology.2013; 14(12): e508. CrossRef Measurements of treatment response in childhood acute leukemia
Dario Campana, Elaine Coustan-Smith
The Korean Journal of Hematology.2012; 47(4): 245. CrossRef Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
Xiao-Su Zhao, Yan-Rong Liu, Hong-Hu Zhu, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Xiao-Jun Huang
Annals of Hematology.2012; 91(2): 183. CrossRef Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
Dario Campana
Current Opinion in Hematology.2012; 19(4): 313. CrossRef
|